Target Gene/Pathway Pathway / Gene

  

Search results

No. KEGG GENES KEGG PATHWAY KEGG DRUG DrugBank Disease ID
1 ESR1 [9] Endocrine resistance, Estrogen signaling pathway, Prolactin signaling pathway, Thyroid hormone signaling pathway, Endocrine and other factor-regulated calcium reabsorption, Pathways in cancer, Proteoglycans in cancer, Chemical carcinogenesis - receptor activation, Breast cancer D08409 Prasterone [6] 49, 53, 83, 86, 96, 113
2 ESR2 [7] Endocrine resistance, Estrogen signaling pathway, Prolactin signaling pathway, GnRH secretion, Pathways in cancer, Chemical carcinogenesis - receptor activation, Breast cancer D08409 Prasterone [6] 49, 53, 83, 86, 96, 113
3 NR3C1 [1] Neuroactive ligand-receptor interaction D00088 Hydrocortisone [4] 83, 97, 98, 299
4 NR3C1 [1] Neuroactive ligand-receptor interaction D00244 Betamethasone [4] 83, 90, 96, 235
5 NR3C1 [1] Neuroactive ligand-receptor interaction D00407 Methylprednisolone [21] 83, 84, 86, 93, 95, 96, 97, 127, 145, 162, 164, 211, 220, 222, 224, 271, 283, 284, 285, 296, 300
6 NR3C1 [1] Neuroactive ligand-receptor interaction D00751 Methylprednisolone [21] 83, 84, 86, 93, 95, 96, 97, 127, 145, 162, 164, 211, 220, 222, 224, 271, 283, 284, 285, 296, 300
7 NR3C1 [1] Neuroactive ligand-receptor interaction D00972 Betamethasone [4] 83, 90, 96, 235
8 NR3C1 [1] Neuroactive ligand-receptor interaction D00976 Hydrocortisone cypionate [1] 83
9 NR3C1 [1] Neuroactive ligand-receptor interaction D00979 Methylprednisolone [21] 83, 84, 86, 93, 95, 96, 97, 127, 145, 162, 164, 211, 220, 222, 224, 271, 283, 284, 285, 296, 300
10 NR3C1 [1] Neuroactive ligand-receptor interaction D01357 Betamethasone [4] 83, 90, 96, 235
11 NR3C1 [1] Neuroactive ligand-receptor interaction D01402 Betamethasone [4] 83, 90, 96, 235
12 NR3C1 [1] Neuroactive ligand-receptor interaction D01442 Hydrocortisone succinate [1] 83
13 NR3C1 [1] Neuroactive ligand-receptor interaction D01637 Betamethasone [4] 83, 90, 96, 235
14 NR3C1 [1] Neuroactive ligand-receptor interaction D02032 Betamethasone [4] 83, 90, 96, 235
15 NR3C1 [1] Neuroactive ligand-receptor interaction D02286 Betamethasone [4] 83, 90, 96, 235
16 NR3C1 [1] Neuroactive ligand-receptor interaction D05000 Methylprednisolone [21] 83, 84, 86, 93, 95, 96, 97, 127, 145, 162, 164, 211, 220, 222, 224, 271, 283, 284, 285, 296, 300
17 NR3C1 [1] Neuroactive ligand-receptor interaction D05001 Methylprednisolone [21] 83, 84, 86, 93, 95, 96, 97, 127, 145, 162, 164, 211, 220, 222, 224, 271, 283, 284, 285, 296, 300
18 NR3C1 [1] Neuroactive ligand-receptor interaction D05002 Methylprednisolone [21] 83, 84, 86, 93, 95, 96, 97, 127, 145, 162, 164, 211, 220, 222, 224, 271, 283, 284, 285, 296, 300
19 AR [4] Oocyte meiosis, Pathways in cancer, Chemical carcinogenesis - receptor activation, Prostate cancer D08409 Prasterone [6] 49, 53, 83, 86, 96, 113
20 MC2R [5] cAMP signaling pathway, Neuroactive ligand-receptor interaction, Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome D00284 Tetracosactide [5] 78, 83, 113, 145, 222
21 MS4A1 [1] Hematopoietic cell lineage D02994 Rituximab [22] 83, 84, 85, 86, 93, 94, 96, 97, 127, 162, 222, 229, 256, 271, 274, 283, 284, 285, 288, 296, 300, 331